Sections

Weather Forecast

Close
Advertisement

FDA says Glaxo vaccine blocks cancer-causing virus

Email Sign up for Breaking News Alerts
news Dickinson, 58602
Dickinson North Dakota 1815 1st Street West 58602

WASHINGTON (AP) -- The Food and Drug Administration says a vaccine from GlaxoSmithKline successfully blocks the virus that causes most cases of cervical cancer.

Advertisement
Advertisement

In documents posted online, the FDA says Cervarix -- Glaxo's vaccine against human papilloma virus or HPV -- successfully blocked the virus nearly 93 percent of the time. Side effects with the vaccine were mild, such as soreness at the injection site.

Cervarix already is approved in nearly 100 other countries, but has been delayed in the U.S. since 2007 when the FDA said it needed additional data.

The agency will ask a panel of vaccine experts next week whether Cervarix should be approved for girls and women ages 10 to 25.

Advertisement
Advertisement
Advertisement
randomness